Showcasing Impactful Implementation of Personalised Medicine Approaches

The number of successful implementations of personalised medicine approaches in healthcare is increasing. However, there is a strong need to facilitate the uptake of further personalised medicine approaches while ensuring a sustainable and effective health system.
To support personalised medicine implementation, the European Partnership for Personalised Medicine (EP PerMed) will not only support personalised medicine research, but also continuously map and communicate on progress and achievements within all personalised medicine related areas. These Best Practice Examples include not only innovations and successful implementation in the clinic or even standard care, but can also be supporting (political) frameworks, successful international or interdisciplinary collaboration or citizen engagement or dissemination campaigns.
By sharing Best Practice Examples, EP PerMed aims to demonstrate the value of personalised medicine in terms of quality of care, quality of life, cost-effectiveness, and sustainability – hoping to motivate others to implement similar approaches.
French National PRecISion Medicine Center in Oncology (IHU PRISM)

EP PerMed awardes the title of “Best Practice” (BP) in Personalised Medicine to the Institut Hospitalo Universitaire PRISM, National PRecISion Medicine Center in Oncology (PRISM) in France. IHU PRISM is a large, multidisciplinary national institute, dedicated to the advancement and implementation of precision oncology across various types of cancer. Its structure integrates clinical trials, molecular profiling, data science, and experimental biology, specifically designed for a comprehensive patient centric approach.
ESR1 Testing via Liquid Biopsy in Metastatic Breast Cancer

EP PerMed awards the title of “Best Practice” (BP) in Personalised Medicine to Cancer Patients Europe (CPE) and Italian patient associations through the development of a White Paper on ESR1 mutations and the use of liquid biopsy in metastatic breast cancer. This effort stands as an excellent example of how patient advocacy can inform and accelerate implementation of personalised medicine tools, support Health Technology Assessment processes, and ultimately improve outcomes for patients.
Regional Healthcare Information Platform in Halland, Sweden

EP PerMed has recently awarded the title of “Best Practice” (BP) in Personalised Medicine to the Regional Healthcare Information Platform in Halland, Sweden. As an integrated healthcare system, Region Halland has committed to fact-based provision, development and research supported by the wealth of data continuously generated in digitalised healthcare. For more than a decade, Region Halland has built information driven care where data science expertise has been added to traditional healthcare competences.
Childhood Cancer in Sweden

EP PerMed awards the title of “Best Practice” (BP) in Personalised Medicine to Genomic Medicine Sweden (GMS) for their national implementation of whole-genome and -transcriptome sequencing in childhood cancer in Sweden (GMS Childhood Cancer). GMS Childhood Cancer is dedicated to ensuring that every child diagnosed with cancer in Sweden has access to the most accurate and personalised diagnostics and treatments available.
Romania’s Pioneering Law: Establishing the Right to Personalised Medicine

This best practice example discusses Romania’s groundbreaking law, the first in the world to recognise the right of citizens and patients to personalised medicine. Initiated following the EU Council’s 2015 personalised medicine policy, the law is the result of a multi-sectoral collaboration led by the Centre for Innovation in Medicine in Romania, using a quadruple helix model (later developed into a penta helix) involving the academia, public, private and civil society sectors. The law, promulgated on 24 May 2023, gives patients a legal right to personalised health care in a manner that takes into account individual genetic and phenotypic characteristics.
Submit your advances and learnings in personalised medicine as a best practice example here: